Has Jeremiah Graff, DPM received payments from drug or device companies?

Yes. Drug and device makers reported $10,979 in general payments to Jeremiah Graff, DPM across 565 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeremiah Graff, DPM did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeremiah Graff, DPM come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeremiah Graff, DPM

Foot & Ankle Surgery · Plano, TXNPI 1689831950

Payments from drug & device makers

$10,979in general payments, 2019–2025

Across 565 payments — averaging $19.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Paratek Pharmaceuticals, Inc.$1K
Smith+Nephew$1K
Amgen$1K
Averitas Pharma Inc.$1K
Stryker$692
AbbVie$687
plus $5K from 54 others

What the payments were for

Food & beverage$10,979100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Paratek Pharmaceuticals, Inc.	95	$1,452
Smith+Nephew	82	$1,347
Amgen(2 entities)	81	$1,210
Averitas Pharma Inc.	33	$1,016
Stryker(2 entities)	15	$692
AbbVie(2 entities)	49	$687
Integra Lifesciences Corporation	15	$349
Sandoz	22	$298
Bone Support Inc.	3	$285
Organogenesis Inc.	15	$272
Melinta Therapeutics, LLC	16	$262
Musculoskeletal Transplant Foundation Inc.	3	$182
Prugen, Inc. Pharmaceuticals	1	$177
Biotronik Inc.	3	$166
Convatec Inc.	6	$163
Ortho Dermatologics, A Division Of Bausch Health US, LLC	10	$159
Tactile Systems Technology Inc	8	$129
Nabriva Therapeutics, PLC	8	$123
Nevro Corp.	7	$121
AstraZeneca	8	$118
IBSA Pharma Inc.	8	$117
Johnson & Johnson	3	$109
Philips North America LLC	4	$108
Baudax Bio Inc.	5	$88
Orthofix Medical, Inc.	6	$87
Kerecis Limited	4	$86
Biotissue Holdings Inc.	3	$85
Innovation Technologies Inc	3	$83
Pylant Medical	1	$67
ANI Pharmaceuticals, Inc.	2	$52
GRT US Holding, Inc.	2	$51
Avita Medical Americas, LLC	1	$47
Bioventus LLC	2	$45
Mimedx Group, Inc.	3	$45
Abbott	2	$43
Imbed Biosciences Inc.	1	$42
Resmed Corp	1	$38
CPM Medical Consultants, LLC	2	$37
Zimmer Biomet	2	$36
Bsn Medical Inc	2	$35
Reapplix Inc.	2	$35
Aroa Biosurgery Incorporated	2	$33
Sebela Pharmaceuticals Inc.	2	$33
Reprise Biomedical, Inc.	2	$32
Reddress USA, Inc.	1	$27
Access Pro Medical, LLC	1	$26
Nuo Therapeutics	2	$26
Avanos Medical	1	$25
Osiris Therapeutics Inc.	2	$24
Medimetriks Pharmaceuticals, Inc.	1	$23
ERMI LLC	1	$22
Inari Medical, Inc.	1	$20
Molnlycke Health Care US, LLC	1	$20
Alfasigma USA, Inc.	1	$17
Forte Bio-pharma LLC	1	$17
Apria Healthcare LLC	1	$16
Nalu Medical, Inc.	1	$14
Misonix Inc	1	$14
Hartmann USA, Inc.	1	$14
Medtronic	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,979 in reported general payments places this provider in the 70th percentile of 684 foot & ankle surgery providers in Texas.

See all foot & ankle surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$1,908,707

Medicare patients

1,116

Services billed

140,301

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Linezolid	49	$3,118
Ciprofloxacin Hcl	178	$2,460
Pregabalin	23	$1,919
Vancomycin Hcl	12	$1,600
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	143	$1,119
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	48	$1,103
Cephalexin	165	$1,056
Gabapentin	85	$762
Levofloxacin	183	$698
Betamethasone Dipropionate	14	$629
Terbinafine Hcl	51	$391
Doxycycline Hyclate	34	$374
Ondansetron Hcl	54	$338
Methylprednisolone	48	$285
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	42	$281

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Plano

Christopher SakowskiPlano$107K
Richard PollakSan Antonio$6.1M
Joseph CaporussoMcAllen$6M
Mark DaltonAustin$4.1M
William McGarveyKaty$3.5M
Eugene CurryDallas$3.1M
Chad HowzeSan Antonio$2.4M
Graham HamiltonEdinburg$2.1M
Kevin VarnerHouston$1.1M
Paul KimDallas$972K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →